Neurocrine Biosciences, Inc.
Pharmaceutical Compositions Comprising an Antipsychotic Drug and a VMAT2 Inhibitor and Uses Thereof
Last updated:
Abstract:
New methods of treating schizophrenia and schizoaffective disorder by administration of pharmaceutical compositions comprising an antipsychotic compound and a VMAT2 inhibitor to a subject in need thereof are provided.
Status:
Application
Type:
Utility
Filling date:
13 Mar 2020
Issue date:
2 Jul 2020